Renalytix AI plc (RENX) - Cash Flow Conversion Efficiency

Latest as of December 2024: 4.746x

Based on the latest financial reports, Renalytix AI plc (RENX) has a cash flow conversion efficiency ratio of 4.746x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-6.50 Million ≈ $-790.50 USD) by net assets (GBX-1.37 Million ≈ $-166.57 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Renalytix AI plc to measure how many days the company can operate on defensive assets alone.

Renalytix AI plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Renalytix AI plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Renalytix AI plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Renalytix AI plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OCA Acquisition Corp NASDAQ:OCAXU	-0.003x
Petros Pharmaceuticals Inc NASDAQ:PTPI	0.156x
BOOSH PLANT-BASED BRANDS F:77I	N/A
LPA Group LSE:LPA	-0.068x
INSURAGUEST TECHN. INC. F:4JG	0.216x
Wishbone Gold Plc LSE:WSBN	-0.187x
TAURUS GOLD CORP. F:W1N	N/A
Marechale Capital Plc LSE:MAC	-0.059x

Annual Cash Flow Conversion Efficiency for Renalytix AI plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Renalytix AI plc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Renalytix AI plc (RENX) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX-7.00 Million ≈ $-851.70	GBX-17.90 Million ≈ $-2.18K	2.557x	-33.30%
2024-06-30	GBX-7.85 Million ≈ $-955.60	GBX-30.11 Million ≈ $-3.66K	3.834x	+744.54%
2023-12-31	GBX20.76 Billion ≈ $2.53 Million	GBX9.43 Billion ≈ $1.15 Million	0.454x	+125.64%
2023-06-30	GBX18.45 Million ≈ $2.25K	GBX-32.67 Million ≈ $-3.98K	-1.771x	-67.09%
2022-06-30	GBX43.17 Million ≈ $5.25K	GBX-45.74 Million ≈ $-5.57K	-1.060x	-309.13%
2021-06-30	GBX95.10 Million ≈ $11.57K	GBX-24.63 Million ≈ $-3.00K	-0.259x	+7.42%
2020-06-30	GBX35.96 Million ≈ $4.38K	GBX-10.06 Million ≈ $-1.22K	-0.280x	-97.30%
2019-06-30	GBX28.17 Million ≈ $3.43K	GBX-3.99 Million ≈ $-485.95	-0.142x	-100.32%
2018-06-30	GBX-9.39K ≈ $-1.14	GBX-422.00K ≈ $-51.35	44.946x	+11298.75%
2016-12-31	GBX17.87 Billion ≈ $2.17 Million	GBX7.05 Billion ≈ $857.42K	0.394x	-6.04%
2015-12-31	GBX17.47 Billion ≈ $2.13 Million	GBX7.33 Billion ≈ $891.85K	0.420x	+30.71%
2014-12-31	GBX17.26 Billion ≈ $2.10 Million	GBX5.54 Billion ≈ $674.42K	0.321x	+4.07%
2013-12-31	GBX20.40 Billion ≈ $2.48 Million	GBX6.29 Billion ≈ $765.80K	0.308x	-28.02%
2012-12-31	GBX21.03 Billion ≈ $2.56 Million	GBX9.01 Billion ≈ $1.10 Million	0.429x	--

About Renalytix AI plc

LSE:RENX UK Health Information Services

Market Cap

$101.03K

GBX830.34 Million GBX

Market Cap Rank

#31287 Global

#1122 in UK

Share Price

GBX1.90

Change (1 day)

+0.00%

52-Week Range

GBX1.80 - GBX10.75

All Time High

GBX1220.00